International Journal of Cancer

Edit Your Profile

International Journal of Cancer Journal

publication venue for

Early-life anthropometry and colorectal cancer risk in adulthood: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis of prospective studies. 157:1094-1109. 2025
Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. 155:400-425. 2024
Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading. 155:471-485. 2024
Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. 155:445-470. 2024
Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. 155:426-444. 2024
Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative. 152:1556-1569. 2023
Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice. 145:2418-2426. 2019
Excess HPV-related head and neck cancer in the world trade center health program general responder cohort. 145:1504-1509. 2019
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers. 142:2263-2272. 2018
Work functioning trajectories in cancer patients: Results from the longitudinal Work Life after Cancer (WOLICA) study. 141:1751-1762. 2017
Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST). 140:1280-1292. 2017
Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα. 134:1195-1206. 2014
Small median tumor diameter at cure threshold (<20 mm) among aggressive non-small cell lung cancers in male smokers predicts both chest X-ray and CT screening outcomes in a novel simulation framework. 132:189-197. 2013
INSL3 has tumor-promoting activity in thyroid cancer. 127:521-531. 2010
MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells. 127:313-320. 2010
OSU03012 activates Erk1/2 and Cdks leading to the accumulation of cells in the S-phase and apoptosis. 123:2923-2930. 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. 122:2017-2022. 2008
Decreasing incidence of cervical adenocarcinoma in Ontario: Is this related to improved endocervical Pap test sampling?. 120:362-367. 2007
Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia. 120:55-59. 2007
Identification of a novel human tissue factor splice variant that is upregulated in tumor cells. 118:1713-1720. 2006
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. 118:103-107. 2006
Assessment of Patient-independent intrinsic error for a noninvasive frame for fractionated stereotactic radiotherapy. 96:320-325. 2001
Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: Influence of family history of ovarian cancer. 81:180-188. 1999
Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. 78:594-599. 1998
Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line. 65:852-857. 1996
Overexpression of the proto-oncogene translation factor 4E in breast-carcinoma cell lines. 65:858-863. 1996
ENGINEERING HIGH-AFFINITY HUMANIZED ANTI-P185(HER2)/ANTI-CD3 BISPECIFIC F(AB')(2) FOR EFFICIENT LYSIS OF P185(HER2) OVEREXPRESSING TUMOR-CELLS. 62:319-324. 1995
Inhibition of effector cell functions in natural killer cell activity (NK) and antibody‐dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera. 25:667-677. 1980
ENGINEERING A HUMANIZED BISPECIFIC-F(AB')2 FRAGMENT FOR IMPROVED BINDING TO T-CELLS 1992
Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck. 2022
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. 2021
Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. 2020
Transcriptome-wide association study reveals candidate causal genes for lung cancer. 2020
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. 2017
Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. 2015
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. 2015
Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). 2014
Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. 2012
Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. 2009
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. 2004
A high prevalence of p53 mutations in pre-malignant oral erythroplakia. 1999
A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. 1995

International Standard Serial Number (ISSN)

0020-7136

Electronic International Standard Serial Number (EISSN)

1097-0215